Division of Endocrinology, Metabolism and Molecular Medicine, Department of Internal Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, California.
David Geffen School of Medicine at University of California, Los Angeles, California.
Am J Physiol Heart Circ Physiol. 2019 Aug 1;317(2):H445-H459. doi: 10.1152/ajpheart.00738.2018. Epub 2019 Jun 7.
Electronic cigarettes (e-cigarettes), also known as electronic nicotine delivery systems, are a popular alternative to conventional nicotine cigarettes, both among smokers and those who have never smoked. In spite of the widespread use of e-cigarettes and the proposed detrimental cardiac and atherosclerotic effects of nicotine, the effects of e-cigarettes on these systems are not known. In this study, we investigated the cardiovascular and cardiac effects of e-cigarettes with and without nicotine in apolipoprotein-E knockout (ApoE) mice. We developed an e-cigarette exposure model that delivers nicotine in a manner similar to that of human e-cigarettes users. Using commercially available e-cigarettes, bluCig PLUS, ApoE mice were exposed to saline, e-cigarette without nicotine [e-cigarette (0%)], and e-cigarette with 2.4% nicotine [e-cigarette (2.4%)] aerosol for 12 wk. Echocardiographic data show that mice treated with e-cigarette (2.4%) had decreased left ventricular fractional shortening and ejection fraction compared with e-cigarette (0%) and saline. Ventricular transcriptomic analysis revealed changes in genes associated with metabolism, circadian rhythm, and inflammation in e-cigarette (2.4%)-treated ApoE mice. Transmission electron microscopy revealed that cardiomyocytes of mice treated with e-cigarette (2.4%) exhibited ultrastructural abnormalities indicative of cardiomyopathy. Additionally, we observed increased oxidative stress and mitochondrial DNA mutations in mice treated with e-cigarette (2.4%). ApoE mice on e-cigarette (2.4%) had also increased atherosclerotic lesions compared with saline aerosol-treated mice. These results demonstrate adverse effects of e-cigarettes on cardiac function in mice. The present study is the first to show that mice exposed to nicotine electronic cigarettes (e-cigarettes) have decreased cardiac fractional shortening and ejection fraction in comparison with controls. RNA-seq analysis reveals a proinflammatory phenotype induced by e-cigarettes with nicotine. We also found increased atherosclerosis in the aortic root of mice treated with e-cigarettes with nicotine. Our results show that e-cigarettes with nicotine lead to detrimental effects on the heart that should serve as a warning to e-cigarette users and agencies that regulate them.
电子香烟(电子烟),也被称为电子尼古丁输送系统,是一种比传统尼古丁香烟更受欢迎的替代品,包括吸烟者和从未吸烟的人。尽管电子烟的广泛使用以及尼古丁对心脏和动脉粥样硬化的潜在有害影响已被提出,但电子烟对这些系统的影响尚不清楚。在这项研究中,我们研究了载脂蛋白 E 敲除(ApoE)小鼠中含尼古丁和不含尼古丁的电子烟的心血管和心脏效应。我们开发了一种电子烟暴露模型,该模型以类似于人类电子烟使用者的方式输送尼古丁。使用市售的电子烟 bluCig PLUS,将 ApoE 小鼠暴露于盐水、不含尼古丁的电子烟(0%)和含 2.4%尼古丁的电子烟(2.4%)气溶胶中 12 周。超声心动图数据显示,与电子烟(0%)和盐水相比,电子烟(2.4%)处理的小鼠左心室分数缩短和射血分数降低。心室转录组分析显示,电子烟(2.4%)处理的 ApoE 小鼠中与代谢、昼夜节律和炎症相关的基因发生变化。透射电子显微镜显示,电子烟(2.4%)处理的小鼠心肌细胞表现出提示心肌病的超微结构异常。此外,我们还观察到电子烟(2.4%)处理的小鼠氧化应激和线粒体 DNA 突变增加。与盐水气雾剂处理的小鼠相比,ApoE 小鼠的电子烟(2.4%)还增加了动脉粥样硬化病变。这些结果表明电子烟对小鼠心脏功能有不良影响。本研究首次表明,与对照组相比,暴露于尼古丁电子烟的小鼠的心脏分数缩短和射血分数降低。RNA-seq 分析显示电子烟诱导的促炎表型。我们还发现,尼古丁电子烟处理的小鼠主动脉根部的动脉粥样硬化增加。我们的研究结果表明,尼古丁电子烟会对心脏造成有害影响,这应该引起电子烟使用者和监管机构的警惕。